High levels of S100A12 are associated with recent plaque symptomatology in patients with carotid atherosclerosis

Stroke

Volumn 43, Issue 5, 2012, Pages 1347-1353

  Abbas, Azhar ^a   Aukrust, Pål ^a   Dahl, Tuva B ^a   Bjerkeli, Vigdis ^a   Sagen, Ellen B Lund ^a   Michelsen, Annika ^a   Russell, David ^a   Sørensen, Kirsten Krohg ^b   Holm, Sverre ^a   Skjelland, Mona ^a   Halvorsen, Bente ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Atherosclerosis; Inflammation; Stroke

Indexed keywords

CALCIUM BINDING PROTEIN; CALGRANULIN; CALGRANULIN A; CALGRANULIN B; GAMMA INTERFERON; INTERLEUKIN 1BETA; MESSENGER RNA; PROTEIN S100A10; PROTEIN S100A12; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

AGED; BIOLOGICAL MARKERS; CALGRANULIN A; CALGRANULIN B; CAROTID ARTERY DISEASES; CAROTID STENOSIS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; RNA, MESSENGER; S100 PROTEINS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 84860221352     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.642256     Document Type: Article

References (27)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation. 2011;123:e18-e209.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
3. Foell D, Wittkowski H, Vogl T, Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol. 2007;81:28-37. (Pubitemid 46021248)
4. Goyette J, Geczy CL. Inflammation-associated S100 proteins: new mechanisms that regulate function. Amino Acids. 2011;41:821-842.
5. Foell D, Wittkowski H, Ren Z, Turton J, Pang G, Daebritz J, et al. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J Pathol. 2008;216:183-192.
6. Perera C, McNeil HP, Geczy CL. S100 Calgranulins in inflammatory arthritis. Immunol Cell Biol. 2010;88:41-49.
7. Ikemoto M, Tanaka T, Takai Y, Murayama H, Tanaka K, Fujita M. New ELISA system for myeloid-related protein complex (MRP8/14) and its clinical significance as a sensitive marker for inflammatory responses associated with transplant rejection. Clin Chem. 2003;49:594-600. (Pubitemid 36379525)
8. Eue I, Langer C, Eckardstein A, Sorg C. Myeloid related protein (MRP) 14 expressing monocytes infiltrate atherosclerotic lesions of ApoE null mice. Atherosclerosis. 2000;151:593-597.
9. McCormick MM, Rahimi F, Bobryshev YV, Gaus K, Zreiqat H, Cai H, et al. S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. J Biol Chem. 2005;280:41521-41529. (Pubitemid 41832213)
10. Foell D, Frosch M, Sorg C, Roth J. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta. 2004;344:37-51. (Pubitemid 38626135)
11. Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, Croce K, et al. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation. 2006;113:2278-2284. (Pubitemid 43947973)
12. Goyette J, Yan WX, Yamen E, Chung YM, Lim SY, Hsu K, et al. Pleiotropic roles of S100A12 in coronary atherosclerotic plaque formation and rupture. J Immunol. 2009;183:593-603.
13. Carotid artery plaque composition-relationship to clinical presentation and ultrasound B-mode imaging. European Carotid Plaque Study Group. Eur J Vasc Endovasc Surg. 1995;10:23-30.
14. Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis-Society of Radiologists in Ultrasound Consensus Conference. Radiology. 2003;229:340-346. (Pubitemid 37310815)
15. Morrow DA, Wang Y, Croce K, Sakuma M, Sabatine MS, Gao H, et al. Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. Am Heart J. 2008;155: 49-55. (Pubitemid 350234770)
16. Hessian PA, Edgeworth J, Hogg N. MRP-8 and MRP-14, two abundant Ca(2)-binding proteins of neutrophils and monocytes. J Leukoc Biol. 1993;53:197-204.
17. Breland UM, Michelsen AE, Skjelland M, Folkersen L, Krohg-Sorensen K, Russell D, et al. Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation. Cardiovasc Res. 2010;86:265-273.
18. Ionita MG, Vink A, Dijke IE, Laman JD, Peeters W, van der Kraak PH, et al. High levels of myeloid-related protein 14 in human atherosclerotic plaques correlate with the characteristics of rupture-prone lesions. Arterioscler Thromb Vasc Biol. 2009;29:1220-1227.
19. Miyamoto S, Ueda M, Ikemoto M, Naruko T, Itoh A, Tamaki S, et al. Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina. Heart. 2008;94:1002-1007. (Pubitemid 352039881)
20. Daugherty A, Rateri DL, Lu H. S100A12 links to thoracic aortic aneurysms. Circ Res. 2010;106:13-15.
21. Mahajan N, Malik N, Bahl A, Dhawan V. Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease. Atherosclerosis. 2009;207:597-602.
22. Mori Y, Kosaki A, Kishimoto N, Kimura T, Iida K, Fukui M, et al. Increased plasma S100A12 (EN-RAGE) levels in hemodialysis patients with atherosclerosis. Am J Nephrol. 2009;29:18-24.
23. Inaba H, Hokamura K, Nakano K, Nomura R, Katayama K, Nakajima A, et al. Upregulation of S100 calcium-binding protein A9 is required for induction of smooth muscle cell proliferation by a periodontal pathogen. FEBS Lett. 2009;583:128-134.
24. Averill MM, Barnhart S, Becker L, Li X, Heinecke JW, Leboeuf RC, et al. S100A9 differentially modifies phenotypic states of neutrophils, macrophages, and dendritic cells: implications for atherosclerosis and adipose tissue inflammation. Circulation. 2011;123:1216-1226.
25. Hofmann BM, Wilk J, Heydemann A, Kim G, Rehman J, Lodato JA, et al. S100A12 mediates aortic wall remodeling and aortic aneurysm. Circ Res. 2010;106:145-154.
26. Yonekawa K, Neidhart M, Altwegg LA, Wyss CA, Corti R, Vogl T, et al. Myeloid related proteins activate Toll-like receptor 4 in human acute coronary syndromes. Atherosclerosis. 2011;218:486-492.
27. Hasegawa T, Kosaki A, Kimura T, Matsubara H, Mori Y, Okigaki M, et al. The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophages. Atherosclerosis. 2003;171:211-218. (Pubitemid 37486072)